Eliquis and Hospitalisation for Women aged 50-59 (a phase IV clinical study of FDA data)

Summary:

Hospitalisation is found for women aged 50-59 who take Eliquis (apixaban). This study is created by eHealthMe based on reports of 4,719 women aged 50-59 from the FDA, and is updated regularly. The information that eHealthMe analyzes includes:

Time on Eliquis when people have Hospitalisation
Top conditions
Top co-used drugs
Top other side effects

On Jul, 03, 2026

4,719 women aged 50-59 reported to have side effects when taking Eliquis.
Among them, 199 people (4.22%) have Hospitalisation

What is Eliquis?

Eliquis has active ingredients of apixaban. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 191,861 Eliquis users. Check the latest studies of Eliquis.

What is Hospitalisation?

Hospitalisation is found to be associated with 1,717 drugs and 1,134 conditions by eHealthMe. Check the latest studies of Hospitalisation.

Number of reports submitted per year:

Could Eliquis cause Hospitalisation in women aged 50-59?

Severity of Hospitalisation

n/a

How people recovered from Hospitalisation

n/a

Top conditions involved for these people *:

You may use this to check any potential undetected conditions.

Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 48 people, 24.12%
Asthma: 27 people, 13.57%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 11 people, 5.53%
Ovarian Cancer (cancer of ovary): 5 people, 2.51%
Short-Bowel Syndrome (a condition in which the body cannot absorb enough fluids and nutrients because part of the small intestine is missing): 4 people, 2.01%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 1.51%
Oedema Peripheral (superficial swelling): 2 people, 1.01%
Back Pain: 2 people, 1.01%
Bladder Disorder: 2 people, 1.01%
Breast Cancer Female: 2 people, 1.01%

Top co-used drugs for these people *:

You may use this to check any potential interacting drugs.

Top other side effects for these people *:

You may use this to check any potential undetected side effects.

Dyspnea (difficult or laboured breathing): 90 people, 45.23%
Headache (pain in head): 89 people, 44.72%
High Blood Pressure: 67 people, 33.67%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 66 people, 33.17%
Asthma: 66 people, 33.17%
Wheezing (a high-pitched whistling sound made while you breath): 64 people, 32.16%
Renal Disorder (kidney disease): 64 people, 32.16%
Cardiac Disorder: 64 people, 32.16%
Sleep Disorder: 64 people, 32.16%
Allergic Rhinitis: 63 people, 31.66%

* Approximation only. Some reports may have incomplete information.

Do you take Eliquis and have Hospitalisation?

- Check whether Hospitalisation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies:

Eliquis and Hospitalisation

How the study uses the data?

The study is based on (applicable) gender, age, apixaban (the active ingredients of Eliquis) and Eliquis (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.